Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
28.02.2022 22:06:36
|
Novavax Inc. Q4 Loss increases, misses estimates
(RTTNews) - Novavax Inc. (NVAX) announced Loss for its fourth quarter that increased from last year and missed the Street estimates.
The company's bottom line came in at -$846.28 million, or -$11.18 per share. This compares with -$177.56 million, or -$2.70 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$1.8 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 20.5% to $222.20 million from $279.66 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings (Q4): -$846.28 Mln. vs. -$177.56 Mln. last year. -EPS (Q4): -$11.18 vs. -$2.70 last year. -Analyst Estimate: -$1.8 -Revenue (Q4): $222.20 Mln vs. $279.66 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
26.02.25 |
Ausblick: Novavax vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
Novavax Inc. | 5,35 | 2,45% |
|